|
| 奥精医疗(688613)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-05-21 | 2807.41 | 21.06% | 13333.33 | 0.00 | 10523.41 | 78.93% | 首发原股东限售股份 | | 2024-05-09 | 221.83 | 1.64% | 10747.75 | 2807.41 | 10747.75 | 79.29% | 股权激励一般股份 | | 2023-05-29 | 166.67 | 1.25% | 10525.92 | 2807.41 | 10523.41 | 78.93% | 首发战略配售股份 | | 2022-05-23 | 7496.80 | 56.23% | 10359.25 | 2974.08 | 10359.25 | 77.69% | 首发原股东限售股份,首发战略配售股份 | | 2021-11-22 | 122.53 | 0.92% | 2862.45 | 10470.88 | 2862.45 | 21.47% | 首发机构配售股份 |
|